- Home
- MMS
MMS
Maximus Inc.
as 07-26-2024 4:00pm EST
Maximus Inc is an operator of government health and human services programs in the United States, United Kingdom, Canada, Australia, and Saudi Arabia. The company offers business solutions to improve the cost-effectiveness, efficiency, and quality of government-sponsored benefit programs, such as Medicaid, Medicare, Health Insurance BC, and child support programmes. Most of its revenue is derived from long-term contractual arrangements with governments around the world. The company generates maximum revenue from the U.S. Federal Services segment.
| Founded: | 1975 | Country: | United States |
| Employees: | N/A | City: | MCLEAN |
| Market Cap: | 5.2B | IPO Year: | 1997 |
| Target Price: | $102.00 | AVG Volume (30 days): | 347.1K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 3.81 | EPS Growth: | 36.07 |
| 52 Week Low/High: | $72.39 - $92.86 | Next Earning Date: | 08-07-2024 |
| Revenue: | $5,124,028,000 | Revenue Growth: | 7.67% |
| Revenue Growth (this year): | 7.86% | Revenue Growth (next year): | 3.48% |
Latest Maximus Inc. News
MMS Breaking Stock News: Dive into MMS Ticker-Specific Updates for Smart Investing
Argus Research
3 days ago
MMS: What does Argus have to say about MMS?
Zacks
4 days ago
Maximus (MMS) Surges 11% in 3 Months: Should You Buy the Stock?
Argus Research
10 days ago
MMS: Raising target price to $101.00
Argus Research
17 days ago
MMS: Lowering target price to $92.00
Business Wire
22 days ago
Maximus Declares Quarterly Cash Dividend of $0.30 per Share
Business Wire
24 days ago
Maximus Schedules Fiscal 2024 Third Quarter Conference Call
Zacks
a month ago
4 Stocks Trading Near 52-Week High That Can Climb Further
MT Newswires
a month ago
Maximus Awarded $87 Million Task Order by Internal Revenue Service
Compare MMS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MMS Maximus Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.